First Time Loading...

AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 18.87 USD -2.08% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

ANAB's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

AnaptysBio, Inc. is a clinical stage biotechnology company. [ Read More ]

The intrinsic value of one ANAB stock under the Base Case scenario is 4.56 USD. Compared to the current market price of 18.87 USD, AnaptysBio Inc is Overvalued by 76%.

Key Points:
ANAB Intrinsic Value
Base Case
4.56 USD
Overvaluation 76%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
AnaptysBio Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ANAB stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
AnaptysBio Inc

Provide an overview of the primary business activities
of AnaptysBio Inc.

What unique competitive advantages
does AnaptysBio Inc hold over its rivals?

What risks and challenges
does AnaptysBio Inc face in the near future?

Has there been any significant insider trading activity
in AnaptysBio Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AnaptysBio Inc.

Provide P/S
for AnaptysBio Inc.

Provide P/E
for AnaptysBio Inc.

Provide P/OCF
for AnaptysBio Inc.

Provide P/FCFE
for AnaptysBio Inc.

Provide P/B
for AnaptysBio Inc.

Provide EV/S
for AnaptysBio Inc.

Provide EV/GP
for AnaptysBio Inc.

Provide EV/EBITDA
for AnaptysBio Inc.

Provide EV/EBIT
for AnaptysBio Inc.

Provide EV/OCF
for AnaptysBio Inc.

Provide EV/FCFF
for AnaptysBio Inc.

Provide EV/IC
for AnaptysBio Inc.

Show me price targets
for AnaptysBio Inc made by professional analysts.

What are the Revenue projections
for AnaptysBio Inc?

How accurate were the past Revenue estimates
for AnaptysBio Inc?

What are the Net Income projections
for AnaptysBio Inc?

How accurate were the past Net Income estimates
for AnaptysBio Inc?

What are the EPS projections
for AnaptysBio Inc?

How accurate were the past EPS estimates
for AnaptysBio Inc?

What are the EBIT projections
for AnaptysBio Inc?

How accurate were the past EBIT estimates
for AnaptysBio Inc?

Compare the revenue forecasts
for AnaptysBio Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AnaptysBio Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AnaptysBio Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of AnaptysBio Inc compared to its peers.

Compare the P/E ratios
of AnaptysBio Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing AnaptysBio Inc with its peers.

Analyze the financial leverage
of AnaptysBio Inc compared to its main competitors.

Show all profitability ratios
for AnaptysBio Inc.

Provide ROE
for AnaptysBio Inc.

Provide ROA
for AnaptysBio Inc.

Provide ROIC
for AnaptysBio Inc.

Provide ROCE
for AnaptysBio Inc.

Provide Gross Margin
for AnaptysBio Inc.

Provide Operating Margin
for AnaptysBio Inc.

Provide Net Margin
for AnaptysBio Inc.

Provide FCF Margin
for AnaptysBio Inc.

Show all solvency ratios
for AnaptysBio Inc.

Provide D/E Ratio
for AnaptysBio Inc.

Provide D/A Ratio
for AnaptysBio Inc.

Provide Interest Coverage Ratio
for AnaptysBio Inc.

Provide Altman Z-Score Ratio
for AnaptysBio Inc.

Provide Quick Ratio
for AnaptysBio Inc.

Provide Current Ratio
for AnaptysBio Inc.

Provide Cash Ratio
for AnaptysBio Inc.

What is the historical Revenue growth
over the last 5 years for AnaptysBio Inc?

What is the historical Net Income growth
over the last 5 years for AnaptysBio Inc?

What is the current Free Cash Flow
of AnaptysBio Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for AnaptysBio Inc.

Financials

Balance Sheet Decomposition
AnaptysBio Inc

Current Assets 406.8m
Cash & Short-Term Investments 390.9m
Receivables 6.9m
Other Current Assets 9.1m
Non-Current Assets 45.6m
Long-Term Investments 27m
PP&E 18.3m
Other Non-Current Assets 256k
Current Liabilities 37.4m
Accounts Payable 4.7m
Accrued Liabilities 32.7m
Non-Current Liabilities 326.8m
Other Non-Current Liabilities 326.8m
Efficiency

Earnings Waterfall
AnaptysBio Inc

Revenue
17.2m USD
Operating Expenses
-181.6m USD
Operating Income
-164.4m USD
Other Expenses
792k USD
Net Income
-163.6m USD

Free Cash Flow Analysis
AnaptysBio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ANAB Profitability Score
Profitability Due Diligence

AnaptysBio Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

Exceptional 1-Year Revenue Growth
Negative Revenue Growth Forecast
Declining ROE
Declining ROIC
11/100
Profitability
Score

AnaptysBio Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

ANAB Solvency Score
Solvency Due Diligence

AnaptysBio Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
54/100
Solvency
Score

AnaptysBio Inc's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ANAB Price Targets Summary
AnaptysBio Inc

Wall Street analysts forecast ANAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANAB is 46.13 USD with a low forecast of 20.2 USD and a high forecast of 84 USD.

Lowest
Price Target
20.2 USD
7% Upside
Average
Price Target
46.13 USD
144% Upside
Highest
Price Target
84 USD
345% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ANAB Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ANAB Price
AnaptysBio Inc

1M 1M
-13%
6M 6M
+11%
1Y 1Y
-10%
3Y 3Y
-22%
5Y 5Y
-75%
10Y 10Y
+11%
Annual Price Range
18.87
52w Low
13.85
52w High
26.47
Price Metrics
Average Annual Return 0.71%
Standard Deviation of Annual Returns 62.59%
Max Drawdown -87%
Shares Statistics
Market Capitalization 501.9m USD
Shares Outstanding 26 763 100
Percentage of Shares Shorted 23.57%

ANAB Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

AnaptysBio Inc Logo
AnaptysBio Inc

Country

United States of America

Industry

Biotechnology

Market Cap

501.9m USD

Dividend Yield

0%

Description

AnaptysBio, Inc. is a clinical stage biotechnology company. The company is headquartered in San Diego, California and currently employs 102 full-time employees. The company went IPO on 2017-01-26. The firm is focused on the immune control mechanisms applicable to inflammation and immuno-oncology indications. The company develops products using antibody discovery technology platform, which is based upon a natural process of antibody generation, known as somatic hypermutation, and replicates this natural process of antibody generation in vitro. Its advanced antibody programs include: Imsidolimab is an antibody that inhibits the interleukin-36 receptor, for the treatment of inflammatory diseases called generalized pustular psoriasis and hidradenitis suppurativa; Rosnilimab is an anti-PD-1 agonist antibody program, is designed to augment PD-1 signaling through Rosnilimab treatment to suppress T-cell driven human inflammatory diseases; anti-BTLA modulator antibody, known as ANB032, is applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation.

Contact

CALIFORNIA
San Diego
10770 Wateridge Circle, Suite 210
+18583626295.0
https://www.anaptysbio.com/

IPO

2017-01-26

Employees

102

Officers

President, CEO & Director
Mr. Daniel R. Faga
Chief Legal Officer
Mr. Eric J. Loumeau
Advisor
Dr. James Newman Topper M.D., Ph.D.
Chief Medical Officer
Dr. Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D.
Chief Financial Officer
Mr. Dennis M. Mulroy
Senior Vice President of Human Resources
Ms. Beth Mueller
Show More
Senior Vice President of Research
Dr. Martin Dahl Ph.D.
Chief Business Officer
Mr. Benjamin Stone
Senior Vice President of CMC
Mr. Douglas A. Rich M.B.A.
Senior Vice President of Corporate Affairs
Ms. Monique Da Silva
Show Less

See Also

Discover More
What is the Intrinsic Value of one ANAB stock?

The intrinsic value of one ANAB stock under the Base Case scenario is 4.56 USD.

Is ANAB stock undervalued or overvalued?

Compared to the current market price of 18.87 USD, AnaptysBio Inc is Overvalued by 76%.